scispace - formally typeset
J

Jun Liu

Researcher at Sun Yat-sen University

Publications -  1474
Citations -  92168

Jun Liu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 100, co-authored 1165 publications receiving 73692 citations. Previous affiliations of Jun Liu include Shanghai Jiao Tong University & Genome Institute of Singapore.

Papers
More filters
Journal ArticleDOI

Freezing of Gait in Parkinson's Disease: Pathophysiology, Risk Factors and Treatments

TL;DR: Several risk factors of FOG have been identified, but need combinatorial optimization for predicting FOG more precisely and firm conclusions cannot be drawn on therapeutic efficacy, although the literature suggested that some therapeutic strategies showed promise.
Journal ArticleDOI

BEST: Binding-site Estimation Suite of Tools

TL;DR: The purpose of the Binding-site Estimation Suite of Tools (BEST) is to provide a platform for using and comparing different motif-finding programs for transcription factor binding site prediction, and to improve the accuracy of these predictions by further optimization.
Journal ArticleDOI

Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.

TL;DR: The results suggest that the PANDAR is a powerful diagnostic and therapeutic marker for patients with GC and, combined with other chemotherapeutics, may have distinct antitumour effects.
Journal ArticleDOI

Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease.

TL;DR: RBD symptoms are common non-motor symptoms of PD, and people with PD are at a higher risk of developing RBD.
Journal ArticleDOI

Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein

TL;DR: This study identified host protein Moloney leukemia virus 10 (MOV10) as an inhibitor of IAV replication, since depletion of Mov10 resulted in a significant increase in virus yield, and potentially provides a new drug design strategy, the use of molecules that mimic the antiviral mechanism of MOV10.